ESPR
Price
$0.99
Change
-$0.03 (-2.94%)
Updated
Jun 27 closing price
Capitalization
495.94M
38 days until earnings call
IXHL
Price
$0.20
Change
-$0.01 (-4.76%)
Updated
Jun 27 closing price
Capitalization
56.83M
Interact to see
Advertisement

ESPR vs IXHL

Header iconESPR vs IXHL Comparison
Open Charts ESPR vs IXHLBanner chart's image
Esperion Therapeutics
Price$0.99
Change-$0.03 (-2.94%)
Volume$4M
Capitalization495.94M
Incannex Healthcare
Price$0.20
Change-$0.01 (-4.76%)
Volume$11.55M
Capitalization56.83M
ESPR vs IXHL Comparison Chart in %
Loading...
ESPR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IXHL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ESPR vs. IXHL commentary
Jun 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ESPR is a Hold and IXHL is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 29, 2025
Stock price -- (ESPR: $0.99 vs. IXHL: $0.20)
Brand notoriety: ESPR and IXHL are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ESPR: 78% vs. IXHL: 19%
Market capitalization -- ESPR: $495.94M vs. IXHL: $56.83M
ESPR [@Pharmaceuticals: Other] is valued at $495.94M. IXHL’s [@Pharmaceuticals: Other] market capitalization is $56.83M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.8B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ESPR’s FA Score shows that 0 FA rating(s) are green whileIXHL’s FA Score has 0 green FA rating(s).

  • ESPR’s FA Score: 0 green, 5 red.
  • IXHL’s FA Score: 0 green, 5 red.
According to our system of comparison, ESPR is a better buy in the long-term than IXHL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ESPR’s TA Score shows that 5 TA indicator(s) are bullish while IXHL’s TA Score has 2 bullish TA indicator(s).

  • ESPR’s TA Score: 5 bullish, 5 bearish.
  • IXHL’s TA Score: 2 bullish, 2 bearish.
According to our system of comparison, both ESPR and IXHL are a good buy in the short-term.

Price Growth

ESPR (@Pharmaceuticals: Other) experienced а -7.29% price change this week, while IXHL (@Pharmaceuticals: Other) price change was -6.44% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +110.28%. For the same industry, the average monthly price growth was +72.48%, and the average quarterly price growth was +80.22%.

Reported Earning Dates

ESPR is expected to report earnings on Aug 05, 2025.

IXHL is expected to report earnings on May 15, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+110.28% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ESPR($496M) has a higher market cap than IXHL($56.8M). ESPR YTD gains are higher at: -54.909 vs. IXHL (-90.330). IXHL has higher annual earnings (EBITDA): -13.64M vs. ESPR (-150.11M). ESPR has more cash in the bank: 82.2M vs. IXHL (14.6M). IXHL has less debt than ESPR: IXHL (470K) vs ESPR (266M). ESPR has higher revenues than IXHL: ESPR (116M) vs IXHL (0).
ESPRIXHLESPR / IXHL
Capitalization496M56.8M873%
EBITDA-150.11M-13.64M1,100%
Gain YTD-54.909-90.33061%
P/E RatioN/AN/A-
Revenue116M0-
Total Cash82.2M14.6M563%
Total Debt266M470K56,596%
FUNDAMENTALS RATINGS
ESPR: Fundamental Ratings
ESPR
OUTLOOK RATING
1..100
70
VALUATION
overvalued / fair valued / undervalued
1..100
36
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ESPRIXHL
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 23 days ago
84%
Bullish Trend 11 days ago
78%
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ESPR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IXHL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
XRAY15.930.09
+0.57%
DENTSPLY SIRONA
GS690.813.65
+0.53%
Goldman Sachs Group
VMD6.920.01
+0.14%
Viemed Healthcare
EXPI9.270.01
+0.11%
eXp World Holdings
ICCM1.01-0.01
-0.63%
IceCure Medical Ltd

ESPR and

Correlation & Price change

A.I.dvisor indicates that over the last year, ESPR has been loosely correlated with ALKS. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if ESPR jumps, then ALKS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ESPR
1D Price
Change %
ESPR100%
-2.75%
ALKS - ESPR
37%
Loosely correlated
-0.12%
DVAX - ESPR
35%
Loosely correlated
-0.40%
AQST - ESPR
30%
Poorly correlated
-0.15%
AMPH - ESPR
27%
Poorly correlated
-0.43%
AMRX - ESPR
26%
Poorly correlated
N/A
More

IXHL and

Correlation & Price change

A.I.dvisor tells us that IXHL and ESPR have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IXHL and ESPR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IXHL
1D Price
Change %
IXHL100%
-1.96%
ESPR - IXHL
23%
Poorly correlated
-2.75%
NBIX - IXHL
22%
Poorly correlated
-1.02%
HROW - IXHL
22%
Poorly correlated
-1.53%
YCBD - IXHL
20%
Poorly correlated
+3.78%
RDY - IXHL
14%
Poorly correlated
-1.70%
More